Labcorp Unveils New Name for Future Independent Clinical Development
https://www.labcorp.com/labcorp-unveils-new-name-future-independent-clinical-development-business-fortrea
WEBFeb 9, 2023 · Upon completion of the spin-off from Labcorp, Fortrea will operate as an independent, publicly traded global CRO that offers comprehensive drug and medical device development services. With over 19,000 people, Fortrea will provide Phase I through IV clinical trial management and commercialization solutions to pharmaceutical …
DA: 25 PA: 60 MOZ Rank: 21